REGULATORY CONSULTING

Medical Device Consultants, Inc. and Boston Healthcare Announce Preferred Vendor Agreement
New Alliance to Increase Breadth of Services Offered
November 28, 2006 - Medical Device Consultants, Inc. (MDCI) and Boston Healthcare Associates, Inc. (BHA) announce a preferred vendor agreement between the two firms.

Medical Device Consultants, Inc., a leading regulatory consulting firm and contract research organization specializing in helping medical device manufacturers understand and overcome the regulatory challenges of launching and maintaining medical devices in the U.S. and EU markets, will join forces with Boston Healthcare Associates, Inc., an advisor to life science companies, helping clients to develop and implement marketing and reimbursement strategies to gain market access, and secure payer reimbursement.

Historically, for medical device manufacturers, FDA approval has been the primary pathway to commercial success. But in today’s cost-conscious health care environment, clients must also be certain that their product will be appropriately covered by payers. A well-planned regulatory strategy that also addresses the issue of reimbursement early on can be critical to U.S. market success. Together the two firms will offer a wide spectrum of highly targeted and effective commercialization strategies and solutions.

"Leveraging the capabilities of both companies allows us to advance our clients´ ability to commercialize novel and innovative medical technologies. The marrying of MDCI’s comprehensive knowledge of FDA and EU regulations with BHA’s proven success in tackling complex market and reimbursement challenges, will help our clients achieve their ultimate business goals”, said BHA President, Andrew Ferrara.

"MDCI is excited to expand our service capabilities for clients," said MDCI’s President, William Morton. "By collaborating and sharing our knowledge and expertise, we can increase the value we bring to clients who seek to bring new medical products to market.”

Under the terms of the agreement, MDCI and BHA will work together to deliver the collaborative benefits of each firm’s regulatory and reimbursement solutions, and will recommend each other’s complementary services. The two organizations will pursue joint opportunities and support each other’s marketing efforts.

About Medical Device Consultants, Inc.
MDCI is a full-service CRO that works with emerging and established firms to commercialize novel and innovative medical devices and diagnostics. MDCI experts provide strategic consulting and tactical solutions to assess and overcome regulatory, quality assurance, and clinical trial challenges at all stages of the medical product lifecycle.

MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally. By leveraging MDCI’s comprehensive knowledge of FDA and international regulations, clients can capture and grow market share, increase productivity, and stay competitive in an increasingly complex global marketplace. Learn more...